DEMANT A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 315.6 DKK | +1.48% |
|
-1.07% | +6.62% |
| Apr. 08 | Denmark's Demant Finalizes Capital Reduction | MT |
| Apr. 04 | Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business | MT |
Business Summary
- tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands;
- hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica;
- diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan;
- business communication solutions (3.7%).
Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).
Number of employees: 21,623
Sales per Business
| DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Hearing Aids
44.7
%
| 8,231 | 41.8 % | 10,036 | 44.7 % | +21.93% |
Hearing Care
40.5
%
| 8,123 | 41.2 % | 9,083 | 40.5 % | +11.82% |
Diagnostics
11.1
%
| 2,291 | 11.6 % | 2,482 | 11.1 % | +8.34% |
Communications - EPOS
3.8
%
| 1,060 | 5.4 % | 842 | 3.8 % | -20.57% |
Sales per region
| DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
34.1
%
| 6,726 | 34.1 % | 7,653 | 34.1 % | +13.78% |
Europe
29.7
%
| 5,655 | 28.7 % | 6,662 | 29.7 % | +17.81% |
Asia
10.4
%
| 1,887 | 9.6 % | 2,331 | 10.4 % | +23.53% |
France
9.9
%
| 2,188 | 11.1 % | 2,214 | 9.9 % | +1.19% |
North America
7.1
%
| 1,352 | 6.9 % | 1,583 | 7.1 % | +17.09% |
Pacific
4.9
%
| 1,055 | 5.4 % | 1,103 | 4.9 % | +4.55% |
Other Regions
2.8
%
| 577 | 2.9 % | 636 | 2.8 % | +10.23% |
Denmark
1.2
%
| 265 | 1.3 % | 261 | 1.2 % | -1.51% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
René Schneider
DFI | Director of Finance/CFO | 51 | 15-08-31 |
Niels Jacobsen
BRD | Director/Board Member | 66 | 91-12-31 |
Peter Pudselykke
IRC | Investor Relations Contact | - | - |
| Sales & Marketing | 43 | - | |
Steen Rosenkvist
AUD | Comptroller/Controller/Auditor | 56 | 12-09-30 |
| Corporate Officer/Principal | - | 16-10-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 07-12-31 | |
Niels Jacobsen
BRD | Director/Board Member | 66 | 91-12-31 |
| Director/Board Member | 57 | 20-12-31 | |
| Director/Board Member | 54 | 20-12-31 | |
Thomas Duer
BRD | Director/Board Member | 51 | 14-12-31 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 221,089,792 | 86,814,715 ( 39.27 %) | 3,386,939 ( 1.532 %) | 39.27 % |
Holdings
| Name | Equities | % | Valuation |
|---|---|---|---|
DEMANT A/S 1.51% | 3,386,939 | 1.51% | 168,531,307 $ |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Oticon A/S
 Oticon A/S Medical SpecialtiesHealth Technology Oticon A/S manufactures equipment and devices for the hearing-impaired. It develops wireless systems, design solutions, and conventional hearing aids. The company sells its products under the brand names Epoq, Delta, Syncro, Safran, Sumo DM, Tego, and Go Pro. Oticon was founded in 1904 and is headquartered Smorum, Denmark. |
Medical Specialties
|
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
315.6
DKK
Average target price
334.1
DKK
Spread / Average Target
+5.87%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.62% | 9.82B | |
| -1.84% | 23.35B | |
| -9.62% | 16.27B | |
| +5.69% | 13.28B | |
| -21.76% | 1.96B | |
| +12.20% | 1.88B | |
| +30.15% | 1.59B | |
| +8.37% | 563M | |
| 0.00% | 497M | |
| +29.68% | 100M |
- Stock Market
- Equities
- DEMANT Stock
- Company Demant A/S
